West Pharmaceutical shares surge 5.18% intraday amid anticipation of strong earnings growth and improved valuation outlook.

West Pharmaceutical Services (WST) surged 5.18% intraday following reports of a 0.6% year-over-year increase in earnings per share (EPS) and 6.1% revenue growth. The rally aligns with the release of earnings data, which, despite prior share price declines and valuation debates, highlighted strong top-line performance. While earlier sessions saw the stock underperform due to broader market weakness, the intraday rebound suggests investor optimism over the earnings results. The firm’s role as a key supplier of high-tech packaging solutions for biopharma, mentioned in non-English reports, may also bolster long-term confidence, though immediate drivers appear tied to the earnings report.